 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/348943
Cross Border Alliances in Biopharma Industry - Survey Report on US Companies
|
Description: |
The Biopharmaceutical Industry is escalating in size with the growth in revenues across the globe. Of late, the industry has been seeing a spurt in mergers and acquisitions, collaborations and alliances. The need for increasingly innovative and successful products has been driving the industry to form strategic alliances and partnerships and this has lead to over 2,600 alliances being signed by the top 20 pharmaceutical players in the last two decades. This model of partnering for research and manufacturing activities reduces risk and provides access to new technologies, coupled with advantages of savings in cost and time.
To understand the US biopharmaceutical industrys views on cross-border alliances, a web-based survey was conducted to capture information on the companies, their plans for entering new markets, and for leveraging partnerships and alliances for growth and profitability. The survey questionnaire was completed by respondents from US companies, of whom 66% were key decision makers. Survey parameters included the strategies of the companies for market expansion, in short run as well as medium term, plans for outsourcing and the types of business models preferred for alliances. This report is useful for the companies to understand the perspectives of the US players so as to enable them to formulate the alliance strategies. |
|
Contents: |
Executive Summary 1. Introduction 2. Objectives of the study 3. Scope of the report 3.1 General Information on the US Companies 3.2 Strategic Agreements and Alliances 3.3 Overseas Services 3.4 Business Expansion Plans 4. Approach and Methodology 5. Analysis and Discussion 5.1 General Information, 5.1.1 Tenure of the Companies in Business 5.1.2 Companies Going Public 5.1.3 Number of Employees in the Company 5.1.4 Companies Annual Revenue for FY2004 5.1.5 Business contributing more than 25% of Revenues 5.1.6 Therapeutic Areas contributing more than 25% of Revenues 5.2 Strategic Agreements and Alliances 5.2.1 Importance of Regions to Revenues or Operations 5.2.2 Companys Operation in each of the Emerging Market Regions 5.2.3 Current Business Cooperation or Alliance with Companies overseas 5.3 Services Provided by Overseas Firms 5.3.1 Type of Business Activity (by region) 5.3.2 Common types of Agreements/Strategies used by Firms when obtaining Products or Services from abroad 5.3.3 Type of Technology/R&D or other services provided by Companies to the following regions 5.3.4 Common types of agreements/strategies used by US firms when providing technology/R&D or other services to overseas companies 5.4 Business Expansion Plans 5.4.1 Intention to enter International Markets in the near future 5.4.2 Market ranking in terms of their importance in Expansion Plans 5.4.3 Time frame planned to enter into China and India 5.4.4 Areas considered for Expanding/Strategic Alliances 5.4.5 Areas Considered for Functional Expansion 5.4.6 Mode of entry into China and India 5.4.7 FDA-Compliant Services Capabilities in China and India 5.4.8 Major Barriers for Entry into India and China 5.4.9 Life sciences firms with the most growth potential 5.4.10 US companies interest in dealing with Chinese and Indian companies 5.4.11 Respondents role in decision-making Conclusion |
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/348943
Order by Fax - using the order form below
Order By Post - print the order form below and send to
 |
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2 Printed 17/02/2012 07:52:06 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
Product Name: |
Cross Border Alliances in Biopharma Industry - Survey Report on US Companies
|
|
Web Address: |
http://www.researchandmarkets.com/reports/348943
|
|
Office Code: |
|
OC8IHINLSNNSS
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Electronic (PDF)
- Single User
|
|
€600.00
|
|
Electronic (PDF)
- Enterprisewide
|
|
€1,800.00
|
Contact information
Please enter all the information below in BLOCK CAPITALS.
 |
|
First Name: |
Last Name: |
|
Email Address: |
 |
|
Job Title: |
 |
|
Organisation: |
 |
|
Address: |
 |
|
City: |
 |
|
Postal/Zip Code: |
 |
|
Country: |
 |
|
Phone Number: |
 |
|
Fax Number: |
 |
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)
 |
Page 2 of 2 Printed 17/02/2012 07:52:06
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
American Express
|
|
Diners Club
|
|
Master Card
|
|
Visa
|
|
|
|
 |
|
Cardholder's Name: |
 |
|
|
|
Cardholder's Signature: |
 |
|
|
|
Expiry Date: |
/  |
|
|
|
Card Number: |
 |
|
|
|
CVV Security Code: |
 |
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
 |
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
 |
|
 |
Please transfer funds to:
 |
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
 |
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)
|
 |
 |
|
|